La Jolla, CA – June 6, 2016 – Synthetic Genomics, Inc. (SGI) announced today that Oliver Fetzer, Ph.D., MBA, Chief Executive Officer of Synthetic Genomics, Inc., will provide a corporate overview and presentation at the Jefferies 2016 Healthcare Conference on Friday, June 10, 2016 at 8:30am ET (5:30am PT) in New York, NY.
https://syntheticgenomics.com/wp-content/uploads/SGI_logo0293746.png00jcalhoonhttps://syntheticgenomics.com/wp-content/uploads/SGI_logo0293746.pngjcalhoon2016-06-06 21:46:252018-04-25 15:13:38Synthetic Genomics, Inc. to Present at the Jefferies 2016 Healthcare Conference
La Jolla, CA — May 3, 2016 — Synthetic Genomics, Inc. (SGI), a leader in the field of synthetic biology, announced today that Anthony Artuso has joined its executive team as Chief Business Officer. Anthony is an accomplished executive and entrepreneur with over 20 years of broad domestic and international experience in biotech, clean energy, finance, public policy, and sustainable development.
https://syntheticgenomics.com/wp-content/uploads/SGI_logo0293746.png00jcalhoonhttps://syntheticgenomics.com/wp-content/uploads/SGI_logo0293746.pngjcalhoon2016-05-03 21:49:182018-04-25 15:14:01Synthetic Genomics, Inc. Hires Anthony Artuso as Chief Business Officer
La Jolla, CA — March 24, 2016 — Researchers from Synthetic Genomics Inc. (SGI) and the J. Craig Venter Institute (JCVI) announced today the design and construction of the first minimal synthetic bacterial cell, JCVI-syn3.0. Using the first synthetic cell, Mycoplasma mycoides JCVI-syn1.0 (created by this same team in 2010), JCVI-syn3.0 was developed through a design, build, and test process using genes from JCVI-syn1.0.
https://syntheticgenomics.com/wp-content/uploads/SGI_logo0293746.png00jcalhoonhttps://syntheticgenomics.com/wp-content/uploads/SGI_logo0293746.pngjcalhoon2016-03-24 21:51:132018-04-25 15:14:25First Minimal Synthetic Bacterial Cell Designed and Constructed by Scientists at Venter Institute and Synthetic Genomics, Inc.
La Jolla, CA – March 3, 2016 – Synthetic Genomics, Inc. (SGI), a leader in the field of synthetic biology, announced today that Robert H. (Rob) Cutler is joining its executive team as General Counsel and Corporate Secretary. Rob has 20 years of corporate legal, intellectual property licensing, regulatory compliance, business development and mergers and acquisitions experience, most of which has been spent in the biotech industry in private and public companies and earlier in his career at leading law firms.
https://syntheticgenomics.com/wp-content/uploads/SGI_logo0293746.png00jcalhoonhttps://syntheticgenomics.com/wp-content/uploads/SGI_logo0293746.pngjcalhoon2016-03-03 21:52:532018-04-25 15:14:43Synthetic Genomics, Inc. Hires Robert H. Cutler as General Counsel
La Jolla, CA – January 13, 2016 – SGI-DNA, a Synthetic Genomics, Inc. (SGI) company, announced today that the world’s first DNA printer, the BioXp™ 3200 System, has reached another milestone with the release of the BioXp™ cloning module.
https://syntheticgenomics.com/wp-content/uploads/SGI_logo0293746.png00jcalhoonhttps://syntheticgenomics.com/wp-content/uploads/SGI_logo0293746.pngjcalhoon2016-01-13 21:54:442018-04-25 15:18:01SGI-DNA Launches Automated Cloning Module for the BioXp™ 3200 System and Reaches another Instrument Milestone
La Jolla, CA – January 6, 2016 – Synthetic Genomics, Inc. (SGI) announced today that Oliver Fetzer, Ph.D., MBA, chief executive officer of Synthetic Genomics, Inc., will provide a corporate overview and presentation at the J.P. Morgan 34th Annual Healthcare Conference on Wednesday, January 13, 2016 at 1:00 p.m. ET (10:00 a.m. PT) in San Francisco, California.
https://syntheticgenomics.com/wp-content/uploads/SGI_logo0293746.png00jcalhoonhttps://syntheticgenomics.com/wp-content/uploads/SGI_logo0293746.pngjcalhoon2016-01-06 21:55:152018-04-25 15:18:13Synthetic Genomics, Inc. to Present at the J.P. Morgan 34th Annual Healthcare Conference
La Jolla, CA — December 15, 2015 — SGI-DNA, a Synthetic Genomics, Inc. (SGI) company, has launched a suite of Cell Engineering Services for generation of custom mammalian cell lines for research use. Cell lines developed using this service are appropriate for the expression of novel proteins as well as a variety of functional studies, including cell-based assays for compound screening.
https://syntheticgenomics.com/wp-content/uploads/SGI_logo0293746.png00jcalhoonhttps://syntheticgenomics.com/wp-content/uploads/SGI_logo0293746.pngjcalhoon2015-12-15 07:05:112018-04-25 15:18:53SGI-DNA Launches Cell Engineering Services for Custom Cell Line Development
La Jolla, CA — December 3, 2015 — SGI-DNA Inc., a Synthetic Genomics Inc. company, announces the launch of beta-testing of the BioXp™ 3200 System Cloning Module, equipping researchers with the ability to synthesize and clone their DNA with an overnight instrument run. The benchtop BioXp™ System, the world’s first DNA printer, is a genomic workstation that generates high-quality DNA from custom designed reagents.
https://syntheticgenomics.com/wp-content/uploads/SGI_logo0293746.png00jcalhoonhttps://syntheticgenomics.com/wp-content/uploads/SGI_logo0293746.pngjcalhoon2015-12-03 07:05:342018-04-25 15:19:32SGI-DNA Launches BioXp™ 3200 System Beta-Testing of a Cloning Module to Provide Scientists the Unprecedented Ability to Synthesize and Clone DNA Virtually Hands-Free
La Jolla, CA— September 22, 2015 — Synthetic Genomics Inc. (SGI), a privately held company developing and commercializing genomic driven advancements in a variety of industries, and Lung Biotechnology PBC, a subsidiary of United Therapeutics Corporation (NASDAQ: UTHR), today announced they have expanded their multi-year research and development agreement to develop transplantation-ready pig organs using synthetic genomic advances.
https://syntheticgenomics.com/wp-content/uploads/SGI_logo0293746.png00jcalhoonhttps://syntheticgenomics.com/wp-content/uploads/SGI_logo0293746.pngjcalhoon2015-09-22 07:07:312018-04-25 15:20:12Synthetic Genomics Inc. Expands Collaborative Research and Development Agreement with Lung Biotechnology PBC, a Subsidiary of United Therapeutics Corporation, to Develop Organs for Transplantation
La Jolla, CA — September 1, 2015 — SGI-DNA, a Synthetic Genomics, Inc. company announces the launch of the Gibson Assembly® Site-Directed Mutagenesis Kit which allows researchers to efficiently and accurately perform site-directed mutagenesis on DNA fragments. This kit is the third in SGI-DNA’s Gibson Assembly® portfolio, which empowers life science researchers to substantially increase their ability […]
https://syntheticgenomics.com/wp-content/uploads/SGI_logo0293746.png00jcalhoonhttps://syntheticgenomics.com/wp-content/uploads/SGI_logo0293746.pngjcalhoon2015-09-01 16:51:382018-04-25 15:20:56SGI-DNA Launches Gibson Assembly® Site-Directed Mutagenesis Kit for Accurate, Robust and Efficient Site-directed Mutagenesis of DNA Fragments
Synthetic Genomics, Inc. to Present at the Jefferies 2016 Healthcare Conference
/in Press Releases /by jcalhoonLa Jolla, CA – June 6, 2016 – Synthetic Genomics, Inc. (SGI) announced today that Oliver Fetzer, Ph.D., MBA, Chief Executive Officer of Synthetic Genomics, Inc., will provide a corporate overview and presentation at the Jefferies 2016 Healthcare Conference on Friday, June 10, 2016 at 8:30am ET (5:30am PT) in New York, NY.
Synthetic Genomics, Inc. Hires Anthony Artuso as Chief Business Officer
/in Press Releases /by jcalhoonLa Jolla, CA — May 3, 2016 — Synthetic Genomics, Inc. (SGI), a leader in the field of synthetic biology, announced today that Anthony Artuso has joined its executive team as Chief Business Officer. Anthony is an accomplished executive and entrepreneur with over 20 years of broad domestic and international experience in biotech, clean energy, finance, public policy, and sustainable development.
First Minimal Synthetic Bacterial Cell Designed and Constructed by Scientists at Venter Institute and Synthetic Genomics, Inc.
/in Press Releases /by jcalhoonLa Jolla, CA — March 24, 2016 — Researchers from Synthetic Genomics Inc. (SGI) and the J. Craig Venter Institute (JCVI) announced today the design and construction of the first minimal synthetic bacterial cell, JCVI-syn3.0. Using the first synthetic cell, Mycoplasma mycoides JCVI-syn1.0 (created by this same team in 2010), JCVI-syn3.0 was developed through a design, build, and test process using genes from JCVI-syn1.0.
Synthetic Genomics, Inc. Hires Robert H. Cutler as General Counsel
/in Press Releases /by jcalhoonLa Jolla, CA – March 3, 2016 – Synthetic Genomics, Inc. (SGI), a leader in the field of synthetic biology, announced today that Robert H. (Rob) Cutler is joining its executive team as General Counsel and Corporate Secretary. Rob has 20 years of corporate legal, intellectual property licensing, regulatory compliance, business development and mergers and acquisitions experience, most of which has been spent in the biotech industry in private and public companies and earlier in his career at leading law firms.
SGI-DNA Launches Automated Cloning Module for the BioXp™ 3200 System and Reaches another Instrument Milestone
/in Press Releases /by jcalhoonLa Jolla, CA – January 13, 2016 – SGI-DNA, a Synthetic Genomics, Inc. (SGI) company, announced today that the world’s first DNA printer, the BioXp™ 3200 System, has reached another milestone with the release of the BioXp™ cloning module.
Synthetic Genomics, Inc. to Present at the J.P. Morgan 34th Annual Healthcare Conference
/in Press Releases /by jcalhoonLa Jolla, CA – January 6, 2016 – Synthetic Genomics, Inc. (SGI) announced today that Oliver Fetzer, Ph.D., MBA, chief executive officer of Synthetic Genomics, Inc., will provide a corporate overview and presentation at the J.P. Morgan 34th Annual Healthcare Conference on Wednesday, January 13, 2016 at 1:00 p.m. ET (10:00 a.m. PT) in San Francisco, California.
SGI-DNA Launches Cell Engineering Services for Custom Cell Line Development
/in Press Releases /by jcalhoonLa Jolla, CA — December 15, 2015 — SGI-DNA, a Synthetic Genomics, Inc. (SGI) company, has launched a suite of Cell Engineering Services for generation of custom mammalian cell lines for research use. Cell lines developed using this service are appropriate for the expression of novel proteins as well as a variety of functional studies, including cell-based assays for compound screening.
SGI-DNA Launches BioXp™ 3200 System Beta-Testing of a Cloning Module to Provide Scientists the Unprecedented Ability to Synthesize and Clone DNA Virtually Hands-Free
/in Press Releases /by jcalhoonLa Jolla, CA — December 3, 2015 — SGI-DNA Inc., a Synthetic Genomics Inc. company, announces the launch of beta-testing of the BioXp™ 3200 System Cloning Module, equipping researchers with the ability to synthesize and clone their DNA with an overnight instrument run. The benchtop BioXp™ System, the world’s first DNA printer, is a genomic workstation that generates high-quality DNA from custom designed reagents.
Synthetic Genomics Inc. Expands Collaborative Research and Development Agreement with Lung Biotechnology PBC, a Subsidiary of United Therapeutics Corporation, to Develop Organs for Transplantation
/in Press Releases /by jcalhoonLa Jolla, CA— September 22, 2015 — Synthetic Genomics Inc. (SGI), a privately held company developing and commercializing genomic driven advancements in a variety of industries, and Lung Biotechnology PBC, a subsidiary of United Therapeutics Corporation (NASDAQ: UTHR), today announced they have expanded their multi-year research and development agreement to develop transplantation-ready pig organs using synthetic genomic advances.
SGI-DNA Launches Gibson Assembly® Site-Directed Mutagenesis Kit for Accurate, Robust and Efficient Site-directed Mutagenesis of DNA Fragments
/in Press Releases /by jcalhoonLa Jolla, CA — September 1, 2015 — SGI-DNA, a Synthetic Genomics, Inc. company announces the launch of the Gibson Assembly® Site-Directed Mutagenesis Kit which allows researchers to efficiently and accurately perform site-directed mutagenesis on DNA fragments. This kit is the third in SGI-DNA’s Gibson Assembly® portfolio, which empowers life science researchers to substantially increase their ability […]